Cargando...

A pharmacokinetic and pharmacodynamic drug interaction between rosuvastatin and valsartan in healthy subjects

PURPOSE: Valsartan, an angiotensin-receptor blocker, and rosuvastatin, a competitive inhibitor of the 3-hydroxy-3-methylglutaryl coenzyme A reductase, are frequently coadministered to treat patients with hypertension and dyslipidemia. The study reported here sought to evaluate the pharmacokinetic an...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Drug Des Devel Ther
Main Authors: Jung, Jin Ah, Lee, Soo-Yun, Kim, Jung-Ryul, Ko, Jae-Wook, Jang, Seong Bok, Nam, Su Youn, Huh, Wooseong
Formato: Artigo
Idioma:Inglês
Publicado: Dove Medical Press 2015
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4354399/
https://ncbi.nlm.nih.gov/pubmed/25767372
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S76942
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!